These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 31168902)
21. Erythema multiforme ("minus" and "maius") and drug intake. Fabbri P; Panconesi E Clin Dermatol; 1993; 11(4):479-89. PubMed ID: 8124636 [No Abstract] [Full Text] [Related]
22. Dimorphic exanthema manifested as reticular maculopapular exanthema and erythema multiforme major associated with pyrazolon derivatives. Chen W; Hsieh FS Eur J Dermatol; 2002; 12(5):488-90. PubMed ID: 12370143 [TBL] [Abstract][Full Text] [Related]
23. Adherence to and gastrointestinal tolerability of monthly oral or quarterly intravenous ibandronate therapy in women with previous intolerance to oral bisphosphonates: a 12-month, open-label, prospective evaluation. Lewiecki EM; Babbitt AM; Piziak VK; Ozturk ZE; Bone HG Clin Ther; 2008 Apr; 30(4):605-21. PubMed ID: 18498910 [TBL] [Abstract][Full Text] [Related]
25. Comparison of clinical effect in treatment of bone tumor between zoledronic acid needle and ibandronate needle. Han J; Han L; Zhang L; Liu X; Zhang J; Zhang H; Wang T Pak J Pharm Sci; 2018 Jul; 31(4(Special)):1683-1686. PubMed ID: 30203762 [TBL] [Abstract][Full Text] [Related]
29. Erythema multiforme-like eruptions associated with etretinate therapy. David M; Sandbank M; Lowe NJ Clin Exp Dermatol; 1989 May; 14(3):230-2. PubMed ID: 2531640 [TBL] [Abstract][Full Text] [Related]
30. Severe erythema exudative multiforme developing from advanced melanoma treated with dabrafenib and trametinib followed by nivolumab. Fujimura T; Kambayashi Y; Hidaka T; Tamabuchi E; Otake E; Tono H; Mizuashi M; Furudate S; Aiba S J Dermatol; 2018 Feb; 45(2):e35-e36. PubMed ID: 28983948 [No Abstract] [Full Text] [Related]
31. The importance of patch tests in the differential diagnosis of adverse drug reactions. Travassos AR; Pacheco D; Antunes J; Silva R; Almeida LS; Filipe P An Bras Dermatol; 2011; 86(4 Suppl 1):S21-3. PubMed ID: 22068762 [TBL] [Abstract][Full Text] [Related]
32. Bad Breaks. Yalla N Clin Chem; 2018 Jan; 64(1):47-50. PubMed ID: 29295835 [No Abstract] [Full Text] [Related]
35. [Drug eruption of erythema multiforme caused by amikacin in a case]. Liu QY; Wang LF Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):187. PubMed ID: 15833189 [No Abstract] [Full Text] [Related]
36. Erythema-multiforme-like eruption on the application site of a nitroglycerin patch, followed by widespread erythema multiforme. Silvestre JF; Betlloch I; Guijarro J; Albares MP; Vergara G Contact Dermatitis; 2001 Nov; 45(5):299-300. PubMed ID: 11722494 [No Abstract] [Full Text] [Related]